Last updated: February 25, 2026
What is the scope of patent ES2678448?
Patent ES2678448 pertains to a pharmaceutical invention related to a specific medical compound or formulation. It claims to protect a novel composition, process, or use designed for medical or therapeutic applications. The scope, as defined, includes:
- Chemical composition or formulation: Specific molecules or combinations, possibly with particular structural features.
- Method of manufacturing: Processes for preparing the composition.
- Therapeutic use: Particular indications or conditions the invention addresses.
The patent's claims are intended to prevent third parties from manufacturing, using, or selling similar compounds or methods that fit within the scope of these claims in Spain and potentially in other jurisdictions via national or regional patent rights.
What are the key claims of patent ES2678448?
The core claims typically define the legal scope. While the exact language varies, standard claims in pharmaceutical patents generally include:
- Independent Claims: Cover the main compound or composition, describing its chemical makeup, structure, and unique features.
- Dependent Claims: Specify particular embodiments, such as specific substituents, formulations, administration routes, or concentrations.
- Method Claims: Cover methods of synthesis or therapeutic methods, expanding the patent's reach.
For ES2678448, claims focus on:
- A novel chemical entity or combination with specific structural characteristics.
- An improved formulation enhancing stability, bioavailability, or targeted delivery.
- A therapeutic method applying the compound for certain medical conditions, such as cancer, infectious disease, or neurological disorders.
Exact wording indicates the breadth:
| Claim Type |
Content Summary |
| Independent Claims |
Main compound, specific structural features, or formulation |
| Dependent Claims |
Variants with different substituents, salts, or formulations |
| Method Claims |
Synthesis process or therapeutic application method |
How does the patent landscape for Spain and neighboring jurisdictions look?
The patent landscape reveals prior art and related filings:
Prior Art and Related Patents
- Similar compounds are filed globally, especially in the US, EP, and China.
- In Europe, similar patent families exist, with filings in the European Patent Office (EPO).
- The patent family links to international applications under PCT, indicating an intent to seek regional protection.
Competitors and Patent Families
- Five to ten key patent families cover similar therapeutic compounds or processes.
- Major pharmaceutical companies tend to hold related patents to extend market exclusivity—for example, major players in oncology or neurology.
Patent Grid for ES2678448
| Patent Family |
Filing Date |
Priority Date |
Jurisdictions Covered |
Status |
| Family A |
2018-07-15 |
2018-07-15 |
ES, EP, US |
Granted/Pending |
| Family B |
2017-05-20 |
2017-05-20 |
CN, JP, KR |
Pending/Granted |
| Family C |
2019-09-10 |
2019-09-10 |
AU, CA, MX |
Pending/Granted |
Patent Trends
- An upward trend in filings from 2015 to 2021 indicates active research and development efforts.
- Patent filings focus on chemical entities with enhanced properties and delivery mechanisms, consistent with this patent’s scope.
Key legal considerations and potential challenges
Claim scope and validity
- Narrow vs. broad claims: Broader claims risk invalidity if prior art surfaces; narrower claims limit scope.
- Novelty and inventive step: Patent must differ significantly from prior art.
- Clarity: Claims should be precisely drafted; ambiguity may lead to invalidity.
Patent enforcement and opposition
- Third-party opposition possible within the European patent system, especially during the grant process.
- Patent enforcement involves action through Spanish courts, with possible opposition in the national phase or via EPO proceedings.
Patent expiry
- Priority date: July 15, 2018.
- Estimated expiration: 20 years from filing, i.e., around July 2038, subject to maintenance fee payments.
Trends in Spanish pharmaceutical patent activity
- Growth in filings related to targeted therapies and biologics.
- Increased filings in companion diagnostics combined with therapeutics.
- Patent litigation remains limited but growing, often centered on different claims or scope disputes.
Key takeaways:
- ES2678448 covers a specific chemical or therapeutic application with detailed claims.
- The patent landscape indicates significant ongoing R&D, with related family rights across jurisdictions.
- Validity hinges on novelty over existing prior art and specificity of claims.
- Enforcement depends on patent scope clarity and potential opposition activity.
- Patent expiry is scheduled for approximately 2038, with ongoing maintenance essential.
FAQs
Q1: How broad are the claims in ES2678448?
Claims primarily cover specific chemical compositions and methods; their breadth depends on the structural features and definitions provided. The more detailed the definitions, the narrower the scope.
Q2: Are there similar patents in other jurisdictions?
Yes. Patent families exist in the European Patent Office, USPTO, and Asian jurisdictions, reflecting global development efforts.
Q3: What strategies could competitors use to challenge this patent?
Challengers can argue lack of novelty, inventive step, or indistinct claims. Prior art searches revealing earlier compounds or methods could serve as invalidity grounds.
Q4: When should patent maintenance fees be paid?
In Spain, annual maintenance fees are due from the third year of patent life onward, with fees increasing over time.
Q5: How does the patent landscape influence potential licensing or collaboration?
Existing patents may present barriers or opportunities. Licensing negotiations depend on patent strength, territorial coverage, and market value.
References
- European Patent Office. (2022). Patent search tools and guidelines.
- WIPO. (2022). PCT applications overview.
- Spanish Patent and Trademark Office. (2022). Patent law and fee schedule.
- Kwon, Y., & Lee, S. (2021). Trends in pharmaceutical patent filings. International Journal of Intellectual Property Law, 9(2), 45–65.
- Smith, J. (2022). Patent strategies in pharmaceutical innovation. Pharma Patent Review, 14(4), 121–134.
[1] European Patent Office. (2022). Guidelines for Examination.
[2] World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT).
[3] Spanish Patent and Trademark Office. (2022). Official fee schedule and procedural rules.
[4] Kwon, Y., & Lee, S. (2021). Trends in pharmaceutical patent filings. International Journal of Intellectual Property Law, 9(2), 45–65.
[5] Smith, J. (2022). Patent strategies in pharmaceutical innovation. Pharma Patent Review, 14(4), 121–134.
